HuGE Literature Finder
Records
1
-
4
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer. PloS one 2022 17 (2): e0262770. Heitz Florian, Lakis Sotirios, Harter Philipp, Heikaus Sebastian, Sehouli Jalid, Talwar Jatin, Menon Roopika, Ataseven Beyhan, Bertrand Miriam, Schneider Stephanie, Mariotti Erika, Bommert Mareike, Müller Judith N, Prader Sonia, Leenders Frauke, Hengsbach Alexandra, Gloeckner Christian, Braicu Elena Ioana, Heukamp Lukas C, du Bois Andreas, Heuckmann Johannes |
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform. Clinical chemistry 2021 Jan . Giménez-Capitán Ana, Bracht Jillian, García Juan José, Jordana-Ariza Núria, García Beatriz, Garzón Mónica, Mayo-de-Las-Casas Clara, Viteri-Ramirez Santiago, Martinez-Bueno Alejandro, Aguilar Andrés, Sullivan Ivana-Gabriela, Johnson Eric, Huang Chung-Ying, Gerlach Jay L, Warren Sarah, Beechem Joseph M, Teixidó Cristina, Rosell Rafael, Reguart Noemí, Molina-Vila Miguel |
Targeted Sequencing of Ascites and Peritoneal Washing Fluid of Patients With Gastrointestinal Cancers and Their Clinical Applications and Limitations. Frontiers in oncology 2021 11 712754. Bae Go Eun, Kim Seok-Hwan, Choi Min Kyung, Kim Jin-Man, Yeo Min-Kyu |
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 May 25 (5): 740-50. McAlpine Jessica N, Porter Henry, Köbel Martin, Nelson Brad H, Prentice Leah M, Kalloger Steve E, Senz Janine, Milne Katy, Ding Jiarui, Shah Sohrab P, Huntsman David G, Gilks C Bla |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: